Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Rayn… (NCT03211325) | Clinical Trial Compass
CompletedNot Applicable
Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
France29 participantsStarted 2016-10-18
Plain-language summary
The investigators seek to perform a comparative transcriptome analysis of TRP channels residing in the skin between primary and scleroderma secondary Raynaud's phenomenon and healthy subjects.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthy volunteers :dated and signed written consent
* Primary Raynaud's patients :
* dated and signed written consent
* subject presenting a primary Raynaud's phenomenon non associated to a connectivite. RP crisis are defined by a succession of caracteristic symptoms : a syncopal phase with distal whitening of the fingers, usually followed by a cyanotic phase, and then a hyperhemic phase with the outbreak of painful redness.The syncopal phase is always present, while the two other phases can be less pronounced, or even absent.
* Sclerodermy secondary Raynaud's patients :
* dated and signed written consent
* subject with Raynaud's phenomenon secondary to systemic sclerosis, according to the 2013 EULAR/ACR criteria.
Exclusion Criteria:
* Minor person or major person protected by the law
* Exclusion period for any clinical trial including a medication or focusing on a clinical device linked to the pathology
* Social secutrity scheme non-affiliated person or person who cannot pretend to such a scheme
* Pregnant woman, parturient or breast-feeding mother
* Person displaying a digital ulcer or a history of digital ulcer
* Severe concurrent disease found at oral questioning : evolutive cancer, hepatic insufficiency, history of myocardic infarction in the past five years, angina pectoris
* Hemodynamic instability
* Any tobacco consumption
* Any contraindication to the medication used in this trial :
* Anesderm ® (lidocain/procain) : Known hypersensitivity, t…
What they're measuring
1
Comparison of the expression of mRNA of different TRP channels between the three groups.